CN Patent

CN107400154A — 一种制备3α,7α-二-羟基-6α-乙基-5β-胆烷酸的方法

Assigned to BEIJING KAWIN TECHNOLOGY Co Ltd · Expires 2017-11-28 · 8y expired

What this patent protects

本发明公开了一种新的制备3α,7α‑二‑羟基‑6α‑乙基‑5β‑胆烷酸(式I)的方法，其中涉及的制备步骤杂质种类少、收率高、纯化方便、操作简单、易于工业化。该化合物用于治疗原发性胆汁性肝硬化和非酒精性脂肪性肝病。

USPTO Abstract

本发明公开了一种新的制备3α,7α‑二‑羟基‑6α‑乙基‑5β‑胆烷酸(式I)的方法，其中涉及的制备步骤杂质种类少、收率高、纯化方便、操作简单、易于工业化。该化合物用于治疗原发性胆汁性肝硬化和非酒精性脂肪性肝病。

Drugs covered by this patent

Patent Metadata

Patent number
CN107400154A
Jurisdiction
CN
Classification
—
Expires
2017-11-28
Drug substance claim
No
Drug product claim
No
Assignee
BEIJING KAWIN TECHNOLOGY Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.